Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer
Public ClinicalTrials.gov record NCT01861054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Study identification
- NCT ID
- NCT01861054
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Dompé Farmaceutici S.p.A
- Industry
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- Reparixin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013
- Primary completion
- Feb 28, 2015
- Completion
- Feb 29, 2016
- Last update posted
- May 13, 2021
2013 – 2016
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202-5289 | — |
| University of Kansas Cancer Center, 4350 Shawnee Mission Pkwy, Suite 1500, Mailstop 6004 | Fairway | Kansas | 66205 | — |
| The Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Montefiore Medical Center, MMC Medical Park at Eastchester | The Bronx | New York | 10461 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Magee-Womens Hospital | Pittsburgh | Pennsylvania | 15213 | — |
| Sara Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| The Methodist Hospital Research Institute | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01861054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01861054 live on ClinicalTrials.gov.